View Clinical Trial (Medical Research Study)

The Effect of Severe Weight Loss and Protein Intake on Bone - NCT00472680-08901(Clinical Trial 169883)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  New Brunswick
State:  
NJ
Zip Code: 08901
Conditions: Weight Loss - Bone Density - Bariatric Surgery
Purpose: The purpose of this study is to learn whether the amount of dietary protein can influence bone health during the weight loss after weight loss surgery.
Study summary: It is unclear whether the amount of protein in the diet during caloric restriction influences bone density. This information is important for determining optimal nutrient requirements during weight loss. This study will examine usual and higher dietary protein intake during severe weight loss following weight loss surgery on bone turnover, mass and quality in women, with the hypothesis that higher protein intake will reduce bone turnover and loss, and/or prevent the changes in bone quality associated with severe weight loss in women ages 18 to 70 years. Participants will be randomly assigned to one of 2 groups: A) weight loss with recommended level of protein intake, or B) weight loss with higher protein intake. A dietitian will provide instructions for a reduced calorie, well balanced diet throughout the 12-month study using a nutrition-education behavior- modification program. Participants will have the opportunity to speak with the dietitian about their diet by phone, or on-site twice per month. In addition they will be asked to take a daily vitamin/mineral supplement and, depending on their usual food intake, they may be asked to take a calcium tablet to meet the recommended intake throughout the study period. Bone, mineral, protein and lipid markers, and hormones that influence bones will be measured. These measurements will provide information about body composition (fat, muscle mass, and bone mineral density).
Criteria: Inclusion Criteria: - Women ages 18 to 70 who are undergoing gastric bypass surgery - Must live in the geographic vicinity of Rutgers University Exclusion Criteria: - Currently on any medication known to influence calcium or bone metabolism, including HRT, or with evidence of diseases known to influence calcium metabolism (i.e. metabolic bone disease, hyperparathyroidism, untreated thyroid disease, significant immune, hepatic, or renal disease, significant cardiac disease [i.e., heart attack or stroke in the past 6 months., abnormal EKG], active malignancy or cancer therapy within the past year) - History of kidney stones - Weight gain or weight loss (5% of body wt) within 3 months prior to recruitment - Participation in other investigational studies during the 12-month study period - Usually have a very high or low intake of calcium (more than 1500 or less than 500 mg per day)
Study is available at: Rutgers University
New Brunswick, NJ 08901
United States

Primary Contact:
Sue Shapses, PhD, RD
Email: shapses@aesop.rutgers.edu
Phone: 732-932-9403
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.